[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Lansoprazole.]
[J01EC02, sulfadiazine, The metabolism of Lansoprazole can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Lansoprazole can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Lansoprazole can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Lansoprazole can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Lansoprazole can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Lansoprazole can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Lansoprazole can be decreased when combined with Sulfisoxazole.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be increased when used in combination with Lansoprazole.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Lansoprazole.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Lansoprazole.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Lansoprazole.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Lansoprazole.]
[B01AE07, dabigatran etexilate, Lansoprazole can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Lansoprazole.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Lansoprazole.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Lansoprazole.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Lansoprazole.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Lansoprazole.]
[L04AX02, thalidomide, The metabolism of Thalidomide can be decreased when combined with Lansoprazole.]
[R03DA04, theophylline, Lansoprazole may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Lansoprazole.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Lansoprazole.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Lansoprazole.]
[B03AB03, sodium ironedetate, Lansoprazole can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AC05, ticlopidine, The metabolism of Lansoprazole can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Lansoprazole.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Lansoprazole.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Lansoprazole.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Lansoprazole.]
[N06AF04, tranylcypromine, The metabolism of Lansoprazole can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Lansoprazole.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Lansoprazole.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Lansoprazole.]
[R03BA07, mometasone, The metabolism of Lansoprazole can be decreased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Lansoprazole.]
[J01EA01, trimethoprim, The metabolism of Lansoprazole can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Lansoprazole.]
[J01FA08, troleandomycin, The metabolism of Lansoprazole can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Lansoprazole.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Lansoprazole.]
[L02BX03, abiraterone, The metabolism of Lansoprazole can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Lansoprazole can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Lansoprazole can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Lansoprazole can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Lansoprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AF01, rivaroxaban, Lansoprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Lansoprazole can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Lansoprazole.]
[N06AX09, viloxazine, The metabolism of Lansoprazole can be decreased when combined with Viloxazine.]
[L01CA02, vincristine, Lansoprazole may decrease the excretion rate of Vincristine which could result in a higher serum level.]
[B01AA03, warfarin, The therapeutic efficacy of Warfarin can be increased when used in combination with Lansoprazole.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Lansoprazole.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Lansoprazole.]
[J05AE02, indinavir, Lansoprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EC01, vemurafenib, Lansoprazole may decrease the excretion rate of Vemurafenib which could result in a higher serum level.]
[M05BA05, tiludronic acid, The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Lansoprazole.]
[L01ED01, crizotinib, The metabolism of Lansoprazole can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Lansoprazole can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Lansoprazole.]
[M05BA06, ibandronic acid, The therapeutic efficacy of Ibandronate can be decreased when used in combination with Lansoprazole.]
[N05AE04, ziprasidone, The metabolism of Lansoprazole can be decreased when combined with Ziprasidone.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Lansoprazole.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Lansoprazole.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Lansoprazole.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Lansoprazole.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Lansoprazole.]
[J02AC03, voriconazole, The metabolism of Lansoprazole can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Lansoprazole.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Lansoprazole.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Lansoprazole.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Lansoprazole.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Lansoprazole.]
[V03AX03, cobicistat, The metabolism of Lansoprazole can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Lansoprazole can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Lansoprazole can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, Lansoprazole can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA31, teriflunomide, The metabolism of Lansoprazole can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, The metabolism of Lansoprazole can be decreased when combined with Regorafenib.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Lansoprazole.]
[J05AE04, nelfinavir, The serum concentration of Nelfinavir can be decreased when it is combined with Lansoprazole.]
[N06DA02, donepezil, Lansoprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Lansoprazole.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Lansoprazole.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Lansoprazole.]
[L01EX07, cabozantinib, The metabolism of Lansoprazole can be decreased when combined with Cabozantinib.]
[G04BE03, sildenafil, The metabolism of Lansoprazole can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Lansoprazole.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Lansoprazole.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Lansoprazole.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Lansoprazole.]
[M04AB03, benzbromarone, The metabolism of Lansoprazole can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, Lansoprazole may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Lansoprazole.]
[M01AH01, celecoxib, Lansoprazole may decrease the excretion rate of Celecoxib which could result in a higher serum level.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Lansoprazole.]
[L01EC02, dabrafenib, The serum concentration of Lansoprazole can be decreased when it is combined with Dabrafenib.]
[L01EE01, trametinib, The metabolism of Lansoprazole can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Lansoprazole.]
[B03AB04, ferric hydroxide, Lansoprazole can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EB03, afatinib, Lansoprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Lansoprazole.]
[J05AJ03, dolutegravir, Lansoprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Lansoprazole.]
[C02KX05, riociguat, Lansoprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Lansoprazole.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Lansoprazole.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Lansoprazole.]
[N03AF04, eslicarbazepine, The metabolism of Lansoprazole can be decreased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Lansoprazole can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Lansoprazole can be decreased when combined with Simeprevir.]
[V03AE05, sucroferric oxyhydroxide, Lansoprazole can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AP08, sofosbuvir, Lansoprazole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Lansoprazole.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Lansoprazole.]
[A16AA07, metreleptin, The metabolism of Lansoprazole can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Lansoprazole can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Lansoprazole can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Lansoprazole.]
[C10AB02, bezafibrate, The metabolism of Lansoprazole can be decreased when combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Lansoprazole can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Lansoprazole can be decreased when combined with Ceritinib.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Lansoprazole.]
[L01EM01, idelalisib, Lansoprazole may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Lansoprazole.]
[V03AE01, polystyrene sulfonate, The therapeutic efficacy of Tolevamer can be decreased when used in combination with Lansoprazole.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Lansoprazole.]
[J01XA05, oritavancin, The metabolism of Lansoprazole can be decreased when combined with Oritavancin.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Lansoprazole.]
[V03AE08, ferric citrate, Lansoprazole can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Lansoprazole.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Lansoprazole.]
[B01AA01, dicumarol, The metabolism of Lansoprazole can be decreased when combined with Dicoumarol.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Lansoprazole.]
[L04AC10, secukinumab, The metabolism of Lansoprazole can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The absorption of Palbociclib can be decreased when combined with Lansoprazole.]
[L01EX08, lenvatinib, Lansoprazole may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Lansoprazole.]
[J05AP06, asunaprevir, Lansoprazole can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Lansoprazole.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Lansoprazole.]
[G02CX02, flibanserin, The serum concentration of Flibanserin can be increased when it is combined with Lansoprazole.]
[S01AA13, fusidic acid, The metabolism of Lansoprazole can be decreased when combined with Fusidic acid.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Lansoprazole.]
[J02AC05, isavuconazole, The metabolism of Lansoprazole can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Lansoprazole may decrease the excretion rate of Osimertinib which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Lansoprazole.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Lansoprazole.]
[A10BB31, acetohexamide, The metabolism of Lansoprazole can be decreased when combined with Acetohexamide.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Lansoprazole.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Lansoprazole.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Lansoprazole.]
[L01XX52, venetoclax, The metabolism of Lansoprazole can be decreased when combined with Venetoclax.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Lansoprazole.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Lansoprazole.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Lansoprazole.]
[N07BC01, buprenorphine, The metabolism of Lansoprazole can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Lansoprazole.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Lansoprazole.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Lansoprazole.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Lansoprazole.]
[L01XK03, rucaparib, Lansoprazole may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[L01EF02, ribociclib, The metabolism of Lansoprazole can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Lansoprazole.]
[J05AE09, tipranavir, The metabolism of Lansoprazole can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Lansoprazole.]
[L04AB02, infliximab, The metabolism of Lansoprazole can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Lansoprazole can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Lansoprazole.]
[J01MA23, delafloxacin, Lansoprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, The metabolism of Lansoprazole can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Lansoprazole.]
[L01EM02, copanlisib, Lansoprazole may decrease the excretion rate of Copanlisib which could result in a higher serum level.]
[L01EF03, abemaciclib, Lansoprazole may decrease the excretion rate of Abemaciclib which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Lansoprazole can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Lansoprazole.]
[R03BA02, budesonide, Lansoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AX18, letermovir, The metabolism of Lansoprazole can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Lansoprazole.]
[A10BK04, ertugliflozin, Lansoprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[C09AA01, captopril, Lansoprazole can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L02BB05, apalutamide, The serum concentration of Lansoprazole can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Lansoprazole can be increased when combined with Carbamazepine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Lansoprazole.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Lansoprazole.]
[B02BX08, avatrombopag, The metabolism of Lansoprazole can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Lansoprazole.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Lansoprazole.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Lansoprazole.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Lansoprazole.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Lansoprazole.]
[L01XX62, ivosidenib, The metabolism of Lansoprazole can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Lansoprazole.]
[N03AX17, stiripentol, The metabolism of Lansoprazole can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Lansoprazole may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AX24, tecovirimat, The metabolism of Lansoprazole can be decreased when combined with Tecovirimat.]
[L01EM04, duvelisib, Lansoprazole may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, Lansoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Lansoprazole.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Lansoprazole.]
[L01XK04, talazoparib, Lansoprazole may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Lansoprazole.]
[R03BB08, revefenacin, Lansoprazole may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Lansoprazole can be increased when combined with Emapalumab.]
[L01XJ03, glasdegib, Lansoprazole may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Lansoprazole.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Lansoprazole.]
[P02BX04, triclabendazole, The metabolism of Lansoprazole can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Lansoprazole.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Lansoprazole.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Lansoprazole.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Lansoprazole.]
[C09CA06, candesartan, The metabolism of Lansoprazole can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Lansoprazole can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Lansoprazole.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Lansoprazole.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Lansoprazole.]
[L02BB06, darolutamide, Lansoprazole may decrease the excretion rate of Darolutamide which could result in a higher serum level.]
[L01EX15, pexidartinib, The serum concentration of Pexidartinib can be decreased when it is combined with Lansoprazole.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Lansoprazole.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Lansoprazole.]
[S01AA27, cefuroxime, The serum concentration of Cefuroxime can be decreased when it is combined with Lansoprazole.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Lansoprazole.]
[N07XX11, pitolisant, The serum concentration of Lansoprazole can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Lansoprazole.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Lansoprazole.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Lansoprazole.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Lansoprazole.]
[G03AC09, desogestrel, The metabolism of Lansoprazole can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Lansoprazole.]
[N03AX25, cenobamate, The serum concentration of Lansoprazole can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Lansoprazole.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Lansoprazole.]
[L01EX18, avapritinib, The metabolism of Lansoprazole can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Lansoprazole.]
[L01XX72, tazemetostat, Lansoprazole may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Lansoprazole.]
[M01AX21, diacetylrhein, The metabolism of Lansoprazole can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Lansoprazole.]
[H02CA02, osilodrostat, The metabolism of Lansoprazole can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Lansoprazole can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, Lansoprazole may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Lansoprazole.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Lansoprazole.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Lansoprazole.]
[M01AH02, rofecoxib, The metabolism of Lansoprazole can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Lansoprazole can be decreased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Lansoprazole can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Lansoprazole can be decreased when combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Lansoprazole can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Lansoprazole.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Lansoprazole.]
[L01EX19, ripretinib, Lansoprazole may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Lansoprazole.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Lansoprazole.]
[J05AX29, fostemsavir, Lansoprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Lansoprazole.]
[L04AC19, satralizumab, The serum concentration of Lansoprazole can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Lansoprazole.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Lansoprazole.]
[L01EX23, pralsetinib, Lansoprazole may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Lansoprazole.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Lansoprazole.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Lansoprazole.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Lansoprazole.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Lansoprazole.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Lansoprazole.]
[A16AX20, lonafarnib, The metabolism of Lansoprazole can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Lansoprazole can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Lansoprazole can be decreased when combined with Tepotinib.]
[V03AF12, trilaciclib, Lansoprazole may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The metabolism of Lansoprazole can be decreased when combined with Felbamate.]
[V08CA07, ferric ammonium citrate, Lansoprazole can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V03AB31, prussian blue insoluble, Lansoprazole can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AB02, iron sucrose, Lansoprazole can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA02, ferrous fumarate, Lansoprazole can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA03, ferrous gluconate, Lansoprazole can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA06, ferrous succinate, Lansoprazole can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA07, ferrous sulfate, Lansoprazole can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Lansoprazole.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Lansoprazole.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Lansoprazole.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Lansoprazole.]
[L03AB10, peginterferon alfa-2b, The metabolism of Lansoprazole can be increased when combined with Peginterferon alfa-2b.]
[B03AB10, ferric maltol, Lansoprazole can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Lansoprazole.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Lansoprazole.]
[L01XX73, sotorasib, The therapeutic efficacy of Sotorasib can be decreased when used in combination with Lansoprazole.]
[L01EN03, infigratinib, The serum concentration of Infigratinib can be decreased when it is combined with Lansoprazole.]
[S03AA07, ciprofloxacin, The metabolism of Lansoprazole can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The serum concentration of Citalopram can be increased when it is combined with Lansoprazole.]
[H01AC07, somapacitan, The metabolism of Lansoprazole can be decreased when combined with Somapacitan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Lansoprazole.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Lansoprazole.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Lansoprazole.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Lansoprazole.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Lansoprazole.]
[A10BB12, glimepiride, The metabolism of Lansoprazole can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Lansoprazole.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Lansoprazole.]
[N06AX25, St. John's wort extract, The metabolism of Lansoprazole can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Lansoprazole can be decreased when combined with Asciminib.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Lansoprazole.]
[B06AX04, mitapivat, The metabolism of Lansoprazole can be increased when combined with Mitapivat.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Lansoprazole.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Lansoprazole.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Lansoprazole.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Lansoprazole.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Lansoprazole.]
[A02BC08, vonoprazan, The metabolism of Lansoprazole can be decreased when combined with Vonoprazan.]
[H01CC04, linzagolix, The serum concentration of Lansoprazole can be increased when it is combined with Linzagolix.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Lansoprazole.]
[N05AH02, clozapine, The metabolism of Lansoprazole can be decreased when combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Lansoprazole can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Lansoprazole can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Lansoprazole.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Lansoprazole.]
[L04AA13, leflunomide, Lansoprazole may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Lansoprazole.]
[J01FA15, telithromycin, The metabolism of Lansoprazole can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Lansoprazole.]
[M01AH03, valdecoxib, The metabolism of Lansoprazole can be decreased when combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Lansoprazole.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Lansoprazole.]
[J02AC02, itraconazole, Lansoprazole can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Lansoprazole.]
[L01EA01, imatinib, Lansoprazole may increase the dermatologic adverse activities of Imatinib.]
[J02AC04, posaconazole, Lansoprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Lansoprazole.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Lansoprazole.]
[R06AX13, loratadine, The metabolism of Lansoprazole can be decreased when combined with Loratadine.]
[C08CA11, manidipine, The metabolism of Lansoprazole can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Lansoprazole.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Lansoprazole.]
[R06AE03, cyclizine, The metabolism of Lansoprazole can be decreased when combined with Cyclizine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Lansoprazole.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Lansoprazole.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Lansoprazole.]
[S01XA18, cyclosporine, The metabolism of Lansoprazole can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Lansoprazole.]
[N06BA07, modafinil, The metabolism of Lansoprazole can be decreased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Lansoprazole.]
[S01XA21, cysteamine, The bioavailability of Cysteamine can be decreased when combined with Lansoprazole.]
[C03XA02, conivaptan, The metabolism of Lansoprazole can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Lansoprazole.]
[M01AH05, etoricoxib, The metabolism of Lansoprazole can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, Lansoprazole may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Lansoprazole can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Lansoprazole can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, Lansoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Lansoprazole.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Lansoprazole.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Lansoprazole.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Lansoprazole.]
[N06AX06, nefazodone, The metabolism of Lansoprazole can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Lansoprazole.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Lansoprazole.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Lansoprazole.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Lansoprazole.]
[L01XA03, oxaliplatin, Lansoprazole may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Lansoprazole can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Lansoprazole can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Lansoprazole can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Lansoprazole.]
[L04AB04, adalimumab, The metabolism of Lansoprazole can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Lansoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06BA02, dextroamphetamine, Lansoprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Lansoprazole.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Lansoprazole.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Lansoprazole.]
[B01AC04, clopidogrel, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Lansoprazole resulting in a loss in efficacy.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Lansoprazole.]
[M05BA02, clodronic acid, The therapeutic efficacy of Clodronic acid can be decreased when used in combination with Lansoprazole.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Lansoprazole.]
[A10BG03, pioglitazone, The metabolism of Lansoprazole can be decreased when combined with Pioglitazone.]
[L01EB02, erlotinib, Lansoprazole can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L02AA01, diethylstilbestrol, The metabolism of Lansoprazole can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Lansoprazole can be decreased when combined with Isradipine.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Lansoprazole.]
[C10AX09, ezetimibe, Lansoprazole may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[N02AA03, hydromorphone, The metabolism of Lansoprazole can be decreased when combined with Hydromorphone.]
[J05AE08, atazanavir, The therapeutic efficacy of Atazanavir can be decreased when used in combination with Lansoprazole.]
[B01AC21, treprostinil, The metabolism of Lansoprazole can be decreased when combined with Treprostinil.]
[C08DB01, diltiazem, The metabolism of Lansoprazole can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Lansoprazole can be decreased when combined with Dimethyl sulfoxide.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Lansoprazole.]
[C05CA03, diosmin, The metabolism of Lansoprazole can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Lansoprazole.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Lansoprazole.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Lansoprazole.]
[N06BA11, dexmethylphenidate, Lansoprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Lansoprazole.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Lansoprazole.]
[S02AA12, rifamycin SV, The metabolism of Lansoprazole can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Lansoprazole can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Lansoprazole may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Lansoprazole.]
[A04AD12, aprepitant, The metabolism of Lansoprazole can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Lansoprazole can be decreased when combined with Bortezomib.]
[J05AE07, fosamprenavir, Lansoprazole can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Lansoprazole.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Lansoprazole.]
[R03AC12, salmeterol, The metabolism of Lansoprazole can be decreased when combined with Salmeterol.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Lansoprazole.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Lansoprazole.]
[L01DB01, doxorubicin, Lansoprazole may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[J01AA02, doxycycline, Lansoprazole can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Lansoprazole.]
[C10AA01, simvastatin, The metabolism of Lansoprazole can be decreased when combined with Simvastatin.]
[N02CC01, sumatriptan, Lansoprazole may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Lansoprazole.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Lansoprazole.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Lansoprazole.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Lansoprazole.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Lansoprazole.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Lansoprazole.]
[N03AX11, topiramate, The metabolism of Lansoprazole can be decreased when combined with Topiramate.]
[C03CA04, torsemide, The metabolism of Lansoprazole can be decreased when combined with Torasemide.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Lansoprazole.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Lansoprazole.]
[C08CA12, mepirodipine, The metabolism of Lansoprazole can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Lansoprazole can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Lansoprazole.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Lansoprazole.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Lansoprazole.]
[N02CA02, ergotamine, The metabolism of Lansoprazole can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Lansoprazole can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Lansoprazole.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Lansoprazole.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Lansoprazole.]
[J04AK02, ethambutol, The metabolism of Lansoprazole can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Lansoprazole can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Lansoprazole can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Lansoprazole can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Lansoprazole can be decreased when combined with Ethinylestradiol.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Lansoprazole.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Lansoprazole.]
[L01CB01, etoposide, Lansoprazole may decrease the excretion rate of Etoposide which could result in a higher serum level.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Lansoprazole.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Lansoprazole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Lansoprazole.]
[R06AX12, terfenadine, The metabolism of Lansoprazole can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Lansoprazole.]
[N06AB08, fluvoxamine, The metabolism of Lansoprazole can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Lansoprazole.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Lansoprazole.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Lansoprazole.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Lansoprazole.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Lansoprazole.]
[C08CA02, felodipine, The metabolism of Lansoprazole can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Lansoprazole.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Lansoprazole.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Lansoprazole.]
[L04AA40, cladribine, Lansoprazole may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Lansoprazole.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Lansoprazole.]
[J02AC01, fluconazole, The metabolism of Lansoprazole can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Lansoprazole.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Lansoprazole.]
[V03AZ01, ethanol, The metabolism of Lansoprazole can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Lansoprazole can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Lansoprazole.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Lansoprazole.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Lansoprazole.]
[V04CX02, folic acid, Lansoprazole may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Lansoprazole.]
[J05AE10, darunavir, The metabolism of Lansoprazole can be decreased when combined with Darunavir.]
[M05BA04, alendronic acid, The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Lansoprazole.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Lansoprazole.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Lansoprazole.]
[C10AB04, gemfibrozil, The metabolism of Lansoprazole can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, Lansoprazole can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Lansoprazole.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Lansoprazole.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Lansoprazole.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Lansoprazole.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Lansoprazole.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Lansoprazole.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Lansoprazole.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Lansoprazole.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Lansoprazole.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Lansoprazole.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Lansoprazole.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Lansoprazole.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Lansoprazole.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Lansoprazole.]
[L01CE02, irinotecan, Lansoprazole may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Lansoprazole.]
[C09CA01, losartan, The metabolism of Lansoprazole can be decreased when combined with Losartan.]
[A07EC02, mesalamine, Lansoprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Lansoprazole.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Lansoprazole.]
[C08CA10, nilvadipine, The metabolism of Lansoprazole can be decreased when combined with Nilvadipine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Lansoprazole.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Lansoprazole.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Lansoprazole.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Lansoprazole.]
[J04AB04, rifabutin, The metabolism of Lansoprazole can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, Lansoprazole can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Lansoprazole.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Lansoprazole.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Lansoprazole.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Lansoprazole.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Lansoprazole.]
[L01CE01, topotecan, Lansoprazole may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Lansoprazole.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Lansoprazole.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Lansoprazole.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Lansoprazole.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Lansoprazole.]
[C10AA06, cerivastatin, Lansoprazole may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Lansoprazole.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Lansoprazole.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Lansoprazole.]
[N06AF05, iproniazid, The metabolism of Lansoprazole can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Lansoprazole can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Lansoprazole can be decreased when combined with Isoniazid.]
[P02CF01, ivermectin, Lansoprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Lansoprazole can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Lansoprazole.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Lansoprazole.]
[J02AB02, ketoconazole, Lansoprazole can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02CA04, levoketoconazole, Lansoprazole can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AH03, olanzapine, The metabolism of Lansoprazole can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The metabolism of Lansoprazole can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Lansoprazole can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Lansoprazole can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Lansoprazole.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Lansoprazole.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Lansoprazole.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Lansoprazole.]
[N06BA13, armodafinil, The metabolism of Lansoprazole can be decreased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Lansoprazole.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Lansoprazole.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Lansoprazole.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Lansoprazole.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Lansoprazole.]
[L01BA05, pralatrexate, Lansoprazole may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Nilotinib can be decreased when it is combined with Lansoprazole.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Lansoprazole.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Lansoprazole.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Lansoprazole.]
[N06DX01, memantine, Lansoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Lansoprazole can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Lansoprazole.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Lansoprazole.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Lansoprazole.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Lansoprazole.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Lansoprazole.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Lansoprazole.]
[J05AF05, lamivudine, Lansoprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01XX05, methenamine, The therapeutic efficacy of Methenamine can be decreased when used in combination with Lansoprazole.]
[H03BB02, methimazole, The metabolism of Lansoprazole can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Lansoprazole may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The serum concentration of Methotrexate can be increased when it is combined with Lansoprazole.]
[N05AA02, methotrimeprazine, The metabolism of Methotrimeprazine can be decreased when combined with Lansoprazole.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Lansoprazole.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Lansoprazole.]
[N06BA04, methylphenidate, Lansoprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Lansoprazole.]
[C07AB02, metoprolol, The metabolism of Metoprolol can be decreased when combined with Lansoprazole.]
[P01AB01, metronidazole, The metabolism of Lansoprazole can be decreased when combined with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Lansoprazole.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Lansoprazole.]
[S02AA13, miconazole, The metabolism of Lansoprazole can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Lansoprazole.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Lansoprazole.]
[G03XB01, mifepristone, The serum concentration of Lansoprazole can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Lansoprazole can be decreased when combined with Valsartan.]
[L01XX23, mitotane, The metabolism of Lansoprazole can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Lansoprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Lansoprazole.]
[C01BD01, amiodarone, The metabolism of Lansoprazole can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Lansoprazole.]
[N02AA01, morphine, The metabolism of Lansoprazole can be decreased when combined with Morphine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Lansoprazole.]
[L04AB05, certolizumab pegol, The metabolism of Lansoprazole can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Lansoprazole can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, Lansoprazole can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA06, mycophenolic acid, Lansoprazole can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AJ01, raltegravir, Lansoprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Lansoprazole.]
[G03XC01, raloxifene, Lansoprazole may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Lansoprazole.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Lansoprazole.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Lansoprazole.]
[V03AB15, naloxone, The metabolism of Lansoprazole can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Lansoprazole can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Lansoprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Lansoprazole.]
[A10BG01, troglitazone, The metabolism of Lansoprazole can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Lansoprazole.]
[L02BG04, letrozole, The metabolism of Lansoprazole can be decreased when combined with Letrozole.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Lansoprazole.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Lansoprazole.]
[N06AX23, desvenlafaxine, The metabolism of Lansoprazole can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The metabolism of Lansoprazole can be decreased when combined with Telmisartan.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Lansoprazole.]
[C08CA04, nicardipine, The metabolism of Lansoprazole can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Lansoprazole.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Lansoprazole.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Lansoprazole.]
[J01XE01, nitrofurantoin, Lansoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[C02KX01, bosentan, The metabolism of Lansoprazole can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Lansoprazole.]
[R05DA07, noscapine, The metabolism of Lansoprazole can be decreased when combined with Noscapine.]
[H01CB02, octreotide, Lansoprazole can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC04, rilonacept, The metabolism of Lansoprazole can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Lansoprazole.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Lansoprazole.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Lansoprazole.]
[V08CB01, ferumoxsil, Lansoprazole can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A14AA08, oxandrolone, The metabolism of Lansoprazole can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The metabolism of Oxprenolol can be decreased when combined with Lansoprazole.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Lansoprazole.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Lansoprazole.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Lansoprazole.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Lansoprazole.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Lansoprazole.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Lansoprazole.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Lansoprazole.]
[N05CA01, pentobarbital, The metabolism of Lansoprazole can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Lansoprazole.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Lansoprazole.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Lansoprazole.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Lansoprazole.]
[N03AA02, phenobarbital, The metabolism of Lansoprazole can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Lansoprazole.]
[M02AA01, phenylbutazone, The metabolism of Lansoprazole can be decreased when combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Lansoprazole.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Lansoprazole.]
[L04AB06, golimumab, The metabolism of Lansoprazole can be increased when combined with Golimumab.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Lansoprazole.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Lansoprazole.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Lansoprazole.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Lansoprazole.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Lansoprazole.]
[J05AE01, saquinavir, The serum concentration of Saquinavir can be increased when it is combined with Lansoprazole.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Lansoprazole.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Lansoprazole.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Lansoprazole.]
[J01DD16, cefditoren, The serum concentration of Cefditoren can be decreased when it is combined with Lansoprazole.]
[J05AG02, delavirdine, Lansoprazole can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C09CA04, irbesartan, The metabolism of Lansoprazole can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Lansoprazole.]
[A10BG02, rosiglitazone, The metabolism of Lansoprazole can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Lansoprazole.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Lansoprazole.]
[L04AC08, canakinumab, The metabolism of Lansoprazole can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Lansoprazole.]
[J05AE03, ritonavir, The serum concentration of Lansoprazole can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Lansoprazole.]
[C10AA08, pitavastatin, Lansoprazole may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Lansoprazole.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Lansoprazole.]
[C02CA01, prazosin, Lansoprazole may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Lansoprazole can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Lansoprazole can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Lansoprazole can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Lansoprazole.]
[C10AB05, fenofibrate, The metabolism of Lansoprazole can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Lansoprazole.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Lansoprazole.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Lansoprazole.]
[R06AD02, promethazine, The metabolism of Lansoprazole can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Propafenone can be decreased when combined with Lansoprazole.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Lansoprazole.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Lansoprazole.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Lansoprazole.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Lansoprazole.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Lansoprazole.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Lansoprazole.]
[P01BD01, pyrimethamine, The metabolism of Lansoprazole can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The metabolism of Lansoprazole can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Lansoprazole.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Lansoprazole.]
[J04AB02, rifampin, Lansoprazole can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A07EC01, sulfasalazine, Lansoprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Lansoprazole.]
[N05CA06, secobarbital, The metabolism of Lansoprazole can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Lansoprazole.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Lansoprazole.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Lansoprazole.]
[C03DA01, spironolactone, The metabolism of Lansoprazole can be decreased when combined with Spironolactone.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Lansoprazole.]
[M05BA01, etidronic acid, The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Lansoprazole.]
[J05AE08, atazanavir, Atazanavir - proton pump inhibitors (PPIs)]
